Kanako Shinada

5PUBLICATIONS
9CO-AUTHORS
Molecular targetsPredictive and prognostic markersInfectious diseasesVenereology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 03, 2024
Comparison of SP263 and 22C3 pharmDx assays to test programmed death ligand-1 (PD-L1) expression in surgically resected non-small cell lung cancer.

Naoko Shigeta, Shuji Murakami, Tomoyuki Yokose

|Jan 10, 2024
Mutation profile and programmed death ligand 1 status of patients with non-small cell lung cancer diagnosed with "adenocarcinoma" and "non-small cell carcinoma favor adenocarcinoma".

Naoko Shigeta, Tomoyuki Yokose, Shuji Murakami

|Aug 29, 2023
Efficacy of osimertinib for lung squamous cell carcinoma with de novo EGFR T790M-positive: Case report and literature review.

Chihiro Maeda, Kanako Shinada, Shuji Murakami

|Jun 14, 2023
High Fever, Wide Distribution of Viral Pneumonia, and Pleural Effusion are More Critical Findings at the First Visit in Predicting the Prognosis of COVID-19: A Single Center, retrospective, Propensity Score-Matched Case-Control Study.

Masahiro Shinoda, Shinichiro Ota, Yuto Yoshida

|Apr 23, 2022
Longitudinal Analysis of Neutralizing Potency against SARS-CoV-2 in the Recovered Patients after Treatment with or without Favipiravir.

Kanako Shinada, Takashi Sato, Saya Moriyama

Pageof 1

Frequent Collaborators

3 joint publications

Shuji Murakami

3 joint publications

Haruhiro Saito

2 joint publications

Takashi Sato

2 joint publications

Masahiro Shinoda